YEAR
- 2017.06.05 Engineered Cpf1 variants with altered PAM specificities Gao L, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F.Nat. Biotechnol. 2017 Aug;35(8):789-792. doi: 10.1038/nbt.3900
- 2017.05.05 Dynamically and epigenetically coordinated GATA/ETS/SOX transcription factor expression is indispensable for endothelial cell differentiation. Kanki Y, Nakaki R, Shimamura T, Matsunaga T, Yamamizu K, Katayama S, Suehiro JI, Osawa T, Aburatani H, Kodama T, Wada Y, Yamashita JK, Minami T.Nucleic Acids Res. 2017 05 05;45(8):4344-4358. doi: 10.1093/nar/gkx159
- 2017.09.01 Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, Yamamoto S, Ichimura K, Nakatomi H, Ueki K, Aburatani H, Saito N.Neuro-oncology. 2017 09 01;19(9):1228-1236. doi: 10.1093/neuonc/nox034
- 2017.05.05 Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase. Ishimoto K, Hayase A, Kumagai F, Kawai M, Okuno H, Hino N, Okada Y, Kawamura T, Tanaka T, Hamakubo T, Sakai J, Kodama T, Tachibana K, Doi T.Biochem. Biophys. Res. Commun. 2017 06 17;488(1):159-164. doi: 10.1016/j.bbrc.2017.04.159
- 2017.12.21 Crystal structures of the TRIC trimeric intracellular cation channel orthologues. Kasuya G, Hiraizumi M, Maturana AD, Kumazaki K, Fujiwara Y, Liu K, Nakada-Nakura Y, Iwata S, Tsukada K, Komori T, Uemura S, Goto Y, Nakane T, Takemoto M, Kato HE, Yamashita K, Wada M, Ito K, Ishitani R, Hattori M, Nureki O.Cell Res. 2016 Dec;26(12):1288-1301. doi: 10.1038/cr.2016.140
- 2017.03.16 Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems Yamada M, Watanabe Y, Gootenberg JS, Hirano H, Ran FA, Nakane T, Ishitani R, Zhang F, Nishimasu H, Nureki O.Mol. Cell. 2017 Mar 16;65(6):1109-1121.e3. doi: 10.1016/j.molcel.2017.02.007
- 2017.04.10 Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia. Okuda H, Stanojevic B, Kanai A, Kawamura T, Takahashi S, Matsui H, Takaori-Kondo A, Yokoyama A.J. Clin. Invest. 2017 May 01;127(5):1918-1931. doi: 10.1172/JCI91406
- 2017.12.17 An Ensemble Docking Calculation of Lysozyme and HyHEL-10: Insight into the Binding Mechanism T. Yamashita and Y. TakamatsuAIP Conf. Proc. 2017, 1906, 030022 https://doi.org/10.1063/1.5012301
CLOSE